-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
POINT Biopharma Global Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and change rate from Q2 2020 to Q1 2023.
- POINT Biopharma Global Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2023 was $146K.
- POINT Biopharma Global Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $130M, a 53.7% decline from 2021.
- POINT Biopharma Global Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $282M, a 884% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)